{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T17:19:32Z","timestamp":1772990372717,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1087363"],"award-info":[{"award-number":["OPP1087363"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The World Health Organization (WHO) recommends oxytocin as the drug of choice for postpartum hemorrhage (PPH) prevention. However, the WHO has also recently considered carbetocin for PPH prevention, but only if carbetocin were a cost-effective choice in the country. Consequently, we determined the cost-effectiveness and budgetary impact of carbetocin against oxytocin in the Philippines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cost-utility analysis using a decision tree was done to compare the costs and outcomes of carbetocin with oxytocin for PPH prophylaxis among women undergoing either vaginal delivery (VD) or cesarean section (CS) in a six-week time horizon using a societal perspective. One-way and probabilistic sensitivity analyses were applied to investigate parameter uncertainties. Additionally, budget impact analysis was conducted using a governmental perspective. Results were presented as incremental cost-effectiveness ratio (ICER) using a 2895 United States dollar (USD) per quality adjusted life year (QALY) gained as the ceiling threshold in the Philippines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Carbetocin was not cost-effective given the listed price of carbetocin at 18 USD. Given a societal perspective, the ICER values of 13,187 USD and over 40,000 USD per QALY gained were derived for CS and VD, respectively. Moreover, the ICER values were sensitive to the risk ratio of carbetocin versus oxytocin and carbetocin price. On budget impact, the five-year total budget impact of a drug mix of carbetocin and oxytocin was 25.54 million USD (4.23 million USD for CS and 21.31 million USD for VD) compared with \u2018\n                      <jats:italic>only oxytocin\u2019<\/jats:italic>\n                      scenario.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Carbetocin is not a cost-effective choice in PPH prevention for both modes of delivery in the Philippines, unless price reduction is made. Our findings can be used for evidence-informed policies to guide coverage decisions on carbetocin not only in the Philippines but also in other low and middle-income countries.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-020-05834-x","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T02:02:51Z","timestamp":1603677771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines"],"prefix":"10.1186","volume":"20","author":[{"given":"Jamaica Roanne","family":"Briones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pattarawalai","family":"Talungchit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montarat","family":"Thavorncharoensap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9457-9823","authenticated-orcid":false,"given":"Usa","family":"Chaikledkaew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"key":"5834_CR1","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/s0140-6736(13)60686-8","volume":"381","author":"JP Souza","year":"2013","unstructured":"Souza JP, G\u00fclmezoglu AM, Vogel J, et al. Moving beyond essential interventions for reduction of maternal mortality (the WHO multicountry survey on maternal and newborn health): a cross-sectional study. Lancet. 2013;381:1747\u201355. https:\/\/doi.org\/10.1016\/s0140-6736(13)60686-8.","journal-title":"Lancet"},{"key":"5834_CR2","doi-asserted-by":"publisher","first-page":"CD011689","DOI":"10.1002\/14651858.CD011689.pub2","volume":"4","author":"ID Gallos","year":"2018","unstructured":"Gallos ID, Williams HM, Price MJ, et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018;4:CD011689. https:\/\/doi.org\/10.1002\/14651858.CD011689.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"5834_CR3","unstructured":"Philippine Statistics Authority. MDG Watch as of May 2016, https:\/\/psa.gov.ph\/sites\/default\/files\/kmcd\/MDG%20Watch%20as%20of%20May2016.pdf (2016, Accessed October 7 2019)."},{"key":"5834_CR4","doi-asserted-by":"publisher","first-page":"e8443","DOI":"10.1097\/MD.0000000000008443","volume":"96","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Yan J, Han Q, et al. Emergency obstetric hysterectomy for life-threatening postpartum hemorrhage: a 12-year review. Medicine (Baltimore). 2017;96:e8443. https:\/\/doi.org\/10.1097\/MD.0000000000008443.","journal-title":"Medicine (Baltimore)"},{"key":"5834_CR5","doi-asserted-by":"publisher","unstructured":"Amornpetchakul P, Lertbunnaphong T, Boriboonhiransarn D, et al. Intravenous carbetocin versus intravenous oxytocin for preventing atonic postpartum hemorrhage after normal vaginal delivery in high-risk singleton pregnancies: a triple-blind randomized controlled trial. Arch Gynecol Obstet. 2018. https:\/\/doi.org\/10.1007\/s00404-018-4806-5.","DOI":"10.1007\/s00404-018-4806-5"},{"key":"5834_CR6","doi-asserted-by":"publisher","first-page":"S184","DOI":"10.3346\/jkms.2016.31.S2.S184","volume":"31 Suppl 2","author":"SH Kim","year":"2016","unstructured":"Kim SH, Lee HJ, Ock M, et al. Disability-Adjusted Life Years for Maternal, Neonatal, and Nutritional Disorders in Korea. J Korean Med Sci. 2016;31 Suppl 2:S184\u201390. https:\/\/doi.org\/10.3346\/jkms.2016.31.S2.S184.","journal-title":"J Korean Med Sci"},{"key":"5834_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/14767058.2014.1002394","volume":"29","author":"B Jin","year":"2016","unstructured":"Jin B, Du Y, Zhang F, et al. Carbetocin for the prevention of postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2016;29:400\u20137. https:\/\/doi.org\/10.3109\/14767058.2014.1002394.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"5834_CR8","first-page":"7","volume":"95","author":"JMA Ann Evensen","year":"2017","unstructured":"Ann Evensen JMA. Patricia Fontaine. Postpartum Hemorrhage: Prevention and Treatment. Am Acad Fam Physicians. 2017;95:7.","journal-title":"Am Acad Fam Physicians"},{"key":"5834_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ejogrb.2017.01.004","volume":"210","author":"HA van der Nelson","year":"2017","unstructured":"van der Nelson HA, Draycott T, Siassakos D, et al. Carbetocin versus oxytocin for prevention of post-partum haemorrhage at caesarean section in the United Kingdom: An economic impact analysis. Eur J Obstet Gynecol Reprod Biol. 2017;210:286\u201391. https:\/\/doi.org\/10.1016\/j.ejogrb.2017.01.004.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5834_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12884-016-1027-4","volume":"16","author":"RJ Nadisauskiene","year":"2016","unstructured":"Nadisauskiene RJ, Dobozinskas P, Kacerauskiene J, et al. The impact of the implementation of the postpartum haemorrhage management guidelines at the first regional perinatal centre in Southern Kazakhstan. BMC Pregnancy Childbirth. 2016;16:238. https:\/\/doi.org\/10.1186\/s12884-016-1027-4.","journal-title":"BMC Pregnancy Childbirth"},{"key":"5834_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jmwh.2007.02.012","volume":"52","author":"S McDonald","year":"2007","unstructured":"McDonald S. Management of the third stage of labor. J Midwifery Womens Health. 2007;52:254\u201361. https:\/\/doi.org\/10.1016\/j.jmwh.2007.02.012.","journal-title":"J Midwifery Womens Health"},{"key":"5834_CR12","unstructured":"World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage, http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/75411\/9789241548502_eng.pdf;jsessionid=756201174802B254E379417B87BC4A24?sequence=1 (2018)."},{"key":"5834_CR13","doi-asserted-by":"publisher","first-page":"e3082","DOI":"10.1002\/psc.3082","volume":"24","author":"M Malm","year":"2018","unstructured":"Malm M, Madsen I, Kjellstrom J. Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries. J Pept Sci. 2018;24:e3082. https:\/\/doi.org\/10.1002\/psc.3082.","journal-title":"J Pept Sci"},{"key":"5834_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa1805489","volume":"379","author":"M Widmer","year":"2018","unstructured":"Widmer M, Piaggio G, Nguyen TMH, et al. Heat-Stable Carbetocin versus Oxytocin to Prevent Hemorrhage after Vaginal Birth. N Engl J Med. 2018;379:743\u201352. https:\/\/doi.org\/10.1056\/NEJMoa1805489.","journal-title":"N Engl J Med"},{"key":"5834_CR15","doi-asserted-by":"publisher","unstructured":"Lawrie TA, Rogozinska E, Sobiesuo P, et al. A systematic review of the cost-effectiveness of uterotonic agents for the prevention of postpartum hemorrhage. Int J Gynaecol Obstet. 2019. https:\/\/doi.org\/10.1002\/ijgo.12836.","DOI":"10.1002\/ijgo.12836"},{"key":"5834_CR16","unstructured":"MIMS. Duratocin\/Duratocin RTS, http:\/\/www.mims.com\/philippines\/drug\/info\/duratocin-duratocin%20rts\/ (2018, Accessed October 03 2018)."},{"key":"5834_CR17","unstructured":"Department of Health. The Philippine Drug Price Reference Index www.dpri.doh.gov.ph (2018)."},{"key":"5834_CR18","unstructured":"Office of the President of the Philippines. Executive Order No. 49, s. 1993 Directing the mandatory use of the Philippine National Formulary (PNF) VOLUME I as the basis of procurement of drug products by the government, https:\/\/www.officialgazette.gov.ph\/1993\/01\/21\/executive-order-no-49-s-1993\/ (1993, Accessed May 21 2020)."},{"key":"5834_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2471\/BLT.14.138206","volume":"93","author":"E Marseille","year":"2015","unstructured":"Marseille E, Larson B, Kazi DS, et al. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015;93:118\u201324. https:\/\/doi.org\/10.2471\/BLT.14.138206.","journal-title":"Bull World Health Organ"},{"key":"5834_CR20","volume-title":"Philippine Peso per US Dollar exchange rate for periods indicated","author":"Bangko Sentral ng Pilipinas","year":"2020","unstructured":"Bangko Sentral ng Pilipinas. Philippine Peso per US Dollar exchange rate for periods indicated. Philippines: Bangko Sentral ng Pilipinas; 2020."},{"key":"5834_CR21","first-page":"22","volume":"4","author":"M Romano","year":"2010","unstructured":"Romano M, Cacciatore A, Giordano R, et al. Postpartum period: three distinct but continuous phases. J Prenat Med. 2010;4:22\u20135.","journal-title":"J Prenat Med"},{"key":"5834_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2217\/cer-2017-0012","volume":"7","author":"SI Caceda","year":"2018","unstructured":"Caceda SI, Ramos RR, Saborido CM. Pharmacoeconomic study comparing carbetocin with oxytocin for the prevention of hemorrhage following cesarean delivery in Lima, Peru. J Comp Eff Res. 2018;7:49\u201355. https:\/\/doi.org\/10.2217\/cer-2017-0012.","journal-title":"J Comp Eff Res"},{"key":"5834_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1055\/s-0038-1655747","volume":"40","author":"Y Gil-Rojas","year":"2018","unstructured":"Gil-Rojas Y, Lasalvia P, Hernandez F, et al. Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia. Rev Bras Ginecol Obstet. 2018;40:242\u201350. https:\/\/doi.org\/10.1055\/s-0038-1655747.","journal-title":"Rev Bras Ginecol Obstet"},{"key":"5834_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2217\/cer-2017-0004","volume":"6","author":"AR Henriquez-Trujillo","year":"2017","unstructured":"Henriquez-Trujillo AR, Lucio-Romero RA, Bermudez-Gallegos K. Analysis of the cost-effectiveness of carbetocin for the prevention of hemorrhage following cesarean delivery in Ecuador. J Comp Eff Res. 2017;6:529\u201336. https:\/\/doi.org\/10.2217\/cer-2017-0004.","journal-title":"J Comp Eff Res"},{"key":"5834_CR25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3109\/01443615.2011.595982","volume":"31","author":"L Higgins","year":"2011","unstructured":"Higgins L, Mechery J, Tomlinson AJ. Does carbetocin for prevention of postpartum haemorrhage at caesarean section provide clinical or financial benefit compared with oxytocin? J Obstet Gynaecol. 2011;31:732\u20139. https:\/\/doi.org\/10.3109\/01443615.2011.595982.","journal-title":"J Obstet Gynaecol"},{"key":"5834_CR26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/01443615.2017.1284188","volume":"37","author":"Y Luni","year":"2017","unstructured":"Luni Y, Borakati A, Matah A, et al. A prospective cohort study evaluating the cost-effectiveness of carbetocin for prevention of postpartum haemorrhage in caesarean sections. J Obstet Gynaecol. 2017;37:601\u20134. https:\/\/doi.org\/10.1080\/01443615.2017.1284188.","journal-title":"J Obstet Gynaecol"},{"key":"5834_CR27","unstructured":"Philippine Obstetrical and Gynecological Society Foundation I. Clinical Practice Guidelines on Abnormal Uterine Bleeding. Philippine Obstetrical and Gynecological Society Foundation, Inc., Philippines. 2017. https:\/\/pogsinc.org\/clinical-practice-guidelines. Accessed 21 May 2020."},{"key":"5834_CR28","unstructured":"Philippine Obstetrical and Gynecological Society and Department of Health. Clinical Practice Guidelines on Intrapartum And Immediate Postpartum Care, http:\/\/www.wpro.who.int\/philippines\/publications\/clinical_practical_guidelines_einc.pdf (2012, Accessed October 7 2018)."},{"key":"5834_CR29","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/s0140-6736(09)61870-5","volume":"375","author":"P Lumbiganon","year":"2010","unstructured":"Lumbiganon P, Laopaiboon M, Gulmezoglu AM, et al. Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007\u201308. Lancet. 2010;375:490\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(09)61870-5.","journal-title":"Lancet"},{"key":"5834_CR30","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1067\/S0002-9378(03)00833-0","volume":"189","author":"DD Mankuta","year":"2003","unstructured":"Mankuta DD, Leshno MM, Menasche MM, et al. Vaginal birth after cesarean section: Trial of labor or repeat csarean section? A decision analysis. Am J Obstetrics Gynecol. 2003;189:714\u20139. Conference Paper. https:\/\/doi.org\/10.1067\/S0002-9378(03)00833-0.","journal-title":"Am J Obstetrics Gynecol"},{"key":"5834_CR31","unstructured":"Philippine Statistics Authority. Summary Inflation Report Consumer Price Index (2012=100): December 2019, https:\/\/psa.gov.ph\/price-indices\/cpi-ir\/title\/Summary%20Inflation%20Report%20Consumer%20Price%20Index%20%282012%3D100%29%3A%20December%202019 (2020)."},{"key":"5834_CR32","unstructured":"Dr. Jose Fabella Memorial Hospital. Annual Health Facility Statistical Report, http:\/\/fabella.doh.gov.ph\/images\/Hospital_Statistics\/stat2016.pdf (2016 )."},{"key":"5834_CR33","volume-title":"Proposal for inclusion of carbetocin in the WHO list of essential medicines","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Proposal for inclusion of carbetocin in the WHO list of essential medicines. Geneva: Switzerland: World Health Organization; 2019."},{"key":"5834_CR34","unstructured":"Department of Health. Administrative Order No. 2016\u20130020 Standardization of per capita budget for meal provisions of patients, https:\/\/qmmc.doh.gov.ph\/attachments\/article\/101\/Per%20Capita%20Budget%20for%20Meal%20Provision%20of%20Patients2.pdf (2016, Accessed October 10 2019)."},{"key":"5834_CR35","unstructured":"Land Transportation Franchising and Regulatory Board. Fare Rates, http:\/\/ltfrb.gov.ph\/index.php\/fare-rates\/ (2019, Accessed May 15, 2019 2019)."},{"key":"5834_CR36","unstructured":"EuroQol Research Foundation. EQ-5D-5L User Guide, https:\/\/euroqol.org\/wp-content\/uploads\/2016\/09\/EQ-5D-5L_UserGuide_2015.pdf (2015)."},{"key":"5834_CR37","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/14737167.2018.1494574","volume":"18","author":"J Pattanaphesaj","year":"2018","unstructured":"Pattanaphesaj J, Thavorncharoensap M, Ramos-Goni JM, et al. The EQ-5D-5L Valuation study in Thailand. Expert RevPharmacoecon Outcomes Res. 2018;18:551\u20138. https:\/\/doi.org\/10.1080\/14737167.2018.1494574.","journal-title":"Expert RevPharmacoecon Outcomes Res"},{"key":"5834_CR38","unstructured":"Ferring Pharmaceuticals. Ferring statement on subsidised pricing of heat-stable carbetocin for the prevention of postpartum haemorrhage in low- and lower-middle income countries. 2019. https:\/\/www.ferring.com\/ferring-statement-on-subsidised-pricing-of-heat-stable-carbetocin-for-the-prevention-of-postpartum-haemorrhage-in-low-and-lower-middle-income-countries\/. Accessed 21 May 2020. Press release."},{"key":"5834_CR39","unstructured":"Philippine Statistics Authority. Registered live births in the Philippines, https:\/\/psa.gov.ph\/sites\/default\/files\/attachments\/crd\/specialrelease\/2017%20Births_SR%20%28approval%29.pdf (2017, Accessed October 03 2018)."},{"key":"5834_CR40","doi-asserted-by":"publisher","unstructured":"Sepehri A, Guliani H. Regional Gradients in Institutional cesarean Delivery Rates: Evidence from Five Countries in Asia. Birth. 2017;44:11\u201320. https:\/\/doi.org\/10.1111\/birt.12265.","DOI":"10.1111\/birt.12265"},{"key":"5834_CR41","unstructured":"Philhealth. List of Medical Case Rates (Updated February 2017), https:\/\/www.philhealth.gov.ph\/circulars\/2017\/annexes\/0019\/AnnexA-MedicalCaseRates.pdf (2017, Accessed May 5 2019)."},{"key":"5834_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jval.2013.08.2291","volume":"17","author":"SD Sullivan","year":"2014","unstructured":"Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget Impact Analysis\u2014Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value in Health. 2014;17:5\u201314. https:\/\/doi.org\/10.1016\/j.jval.2013.08.2291.","journal-title":"Value in Health"},{"key":"5834_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13063-018-3109-2","volume":"20","author":"H van der Nelson","year":"2019","unstructured":"van der Nelson H, O'Brien S, Lenguerrand E, et al. Intramuscular oxytocin versus oxytocin\/ergometrine versus carbetocin for prevention of primary postpartum haemorrhage after vaginal birth: study protocol for a randomised controlled trial (the IMox study). Trials. 2019;20:4. https:\/\/doi.org\/10.1186\/s13063-018-3109-2.","journal-title":"Trials"},{"key":"5834_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/jog.13486","volume":"44","author":"HY Voon","year":"2018","unstructured":"Voon HY, Shafie AA, Bujang MA, et al. Cost effectiveness analysis of carbetocin during cesarean section in a high volume maternity unit. J Obstet Gynaecol Res. 2018;44:109\u201316. https:\/\/doi.org\/10.1111\/jog.13486.","journal-title":"J Obstet Gynaecol Res"},{"key":"5834_CR45","unstructured":"Philhealth. PhilHealth Guarantees Not One Filipino Should Be Left Behind, https:\/\/www.philhealth.gov.ph\/news\/2018\/ph_guarantees.html (2018)."},{"key":"5834_CR46","volume-title":"Profile of private hospitals in the Philippines","author":"R Lavado","year":"2011","unstructured":"Lavado R, Pantig I, Ulep V, et al. Profile of private hospitals in the Philippines. 2011."},{"key":"5834_CR47","doi-asserted-by":"publisher","first-page":"e1001525","DOI":"10.1371\/journal.pmed.1001525","volume":"10","author":"JP Souza","year":"2013","unstructured":"Souza JP. The prevention of postpartum hemorrhage in the community. PLoS Med. 2013;10:e1001525. https:\/\/doi.org\/10.1371\/journal.pmed.1001525.","journal-title":"PLoS Med"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05834-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-020-05834-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05834-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T19:21:49Z","timestamp":1635189709000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-020-05834-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5834"],"URL":"https:\/\/doi.org\/10.1186\/s12913-020-05834-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.23167\/v1","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,26]]},"assertion":[{"value":"30 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Faculty of Dentistry\/ Faculty of Pharmacy, Mahidol University, Institutional Review Board reviewed the protocol and granted the ethics approval to conduct cost-utility analysis which cost and utility data were collected from two settings. First, for cost data, hospital charges were retrospectively gathered form Hospital billing records after the approval of the Ethics Committee of Dr. Jose Fabella Memorial Hospital - Manila, Philippines (REC-2019-004 ver. 1). Written consent was waived since billing charges were obtained retrospectively and patients were not interviewed for the costing data. Second, the utility data were collected from women who gave birth through VD or CS using EQ-5D-5L questionnaires and gathered after approval of the Institutional Review Board (IRB) of Siriraj Hospital \u2013 Bangkok, Thailand (COA. No. Si 128\/2019) where written consent was obtained before administering the questionnaires.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"975"}}